 BioCryst Pharmaceuticals, Inc. NASDAQ:BCRX Q3 2022 Earnings Conference Call November 1, 2022 8:30 AM ET Company Participants John Bluth - SVP, IR and Corporate Communications Jon Stonehouse - Chief Executive Officer Anthony Doyle - Chief Financial Officer Charlie Gayer - Chief Commercial Officer Helen Thackray - Chief RD Officer Conference Call Participants Ken Cacciatore - Cowen and Company Chris Raymond - Piper Sandler Daniel Wolle - JPMorgan Joe Spak - RBC Capital Jon Wolleben - JMP Securities Gena Wang - Barclays Justin Kim - Oppenheimer Company Tazeen Ahmad - Bank of America Rohit Bhasin - Needham Company Maury Raycroft - Jefferies Operator Hello, and welcome to the BioCryst Third Quarter 2022 Earnings Conference Call. My name is Michelle and I will be your operator for todays conference. 